Andrew Nisbet - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Andrew Nisbet's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Andrew Nisbet
Verified
Editor-in-Chief (Scientific), British Journal of Radiology
London
Beats
rico, puerto
Content
By Priyanka Gupta, Umber Cheema, Andrew Nisbet, Anna-Dimitra Kataki| ACS Publications@ 1. IntroductionClick to copy section linkSection link copied!Termed as a “silent killer,” pancreatic ductal adenocarcinoma (PDAC), a malignancy of the pancreas, exhibits a devastating 5-year survival rate of only ∼13% with minimal improvement observed over the past decade. (1) A key factor contributing to these disheartening outcomes is the significant resistance of PDAC to conventional treatment modalities, including chemotherapy and radiotherapy.
By Gabrielle Wishart, Priyanka Gupta, Andrew Nisbet, Eirini Velliou| birpublications.org@ Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
By Priyanka Gupta, Umber Cheema, Andrew Nisbet, Anna-Dimitra Kataki| ACS Publications@ 1. IntroductionClick to copy section linkSection link copied!Termed as a “silent killer,” pancreatic ductal adenocarcinoma (PDAC), a malignancy of the pancreas, exhibits a devastating 5-year survival rate of only ∼13% with minimal improvement observed over the past decade. (1) A key factor contributing to these disheartening outcomes is the significant resistance of PDAC to conventional treatment modalities, including chemotherapy and radiotherapy.
Company Info
British Journal of Radiology
London, England, United Kingdom
+44 20 7679 2000